Status:
COMPLETED
Antidepressant Use During Pregnancy
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Depression
Eligibility:
FEMALE
18-45 years
Brief Summary
This study will determine the safety of antidepressant use during pregnancy for both the mother and the child.
Detailed Description
Symptoms of major depressive disorder (MDD) include persistent sad mood, feelings of hopelessness or guilt, decreased energy, irritability, and more. If untreated, MDD can interfere with the ability t...
Eligibility Criteria
Inclusion
- Less than 24 weeks pregnant at the time of study entry
- As of 12/1/2005, at significant risk for developing depression or currently taking SSRIs during pregnancy
Exclusion
- History of or current psychosis, bipolar disorder, or schizoaffective disorder
- Current substance use disorder
- Any medical condition that may be related to outcomes (such as multiple births or insulin-dependent diabetes)
- Has not attended at least two prenatal visits at the 20-week intake point
Key Trial Info
Start Date :
September 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
283 Patients enrolled
Trial Details
Trial ID
NCT00279370
Start Date
September 1 1999
End Date
December 1 2009
Last Update
October 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Behavioral HealthCARE Program
Pittsburgh, Pennsylvania, United States, 15213